System-wide identification of wild-type SUMO-2 conjugation sites

Nature Communications

Volumn 6, Issue , 2015, Pages

  Hendriks, Ivo A ^a   D'Souza, Rochelle C ^b   Chang, Jer Gung ^a   Mann, Matthias ^b   Vertegaal, Alfred C O ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HISTIDINE; LYSINE; PROTEINASE; SENP2 PROTEIN; SUMO 2 PROTEIN; UNCLASSIFIED DRUG; PROTEIN; SUMO PROTEIN; SUMO2 PROTEIN, HUMAN;

AMINO ACID; CELLS AND CELL COMPONENTS; ENZYME ACTIVITY; HEAT SHOCK; IDENTIFICATION METHOD; MAMMAL; MASS SPECTROMETRY; MUTATION; PROTEIN;

ARTICLE; CONJUGATION; CONTROLLED STUDY; HELA CELL LINE; HUMAN; HUMAN CELL; MAMMAL; MASS SPECTROMETRY; PROTEASE RELIANT IDENTIFICATION OF SUMO MODIFICATION; PROTEIN ANALYSIS; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS; SUMOYLATION; WILD TYPE; ELECTROPHORESIS; IMMUNOBLOTTING; LIQUID CHROMATOGRAPHY; METABOLISM; PROTEOMICS; TANDEM MASS SPECTROMETRY;

MAMMALIA;

CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS; HELA CELLS; HUMANS; IMMUNOBLOTTING; MASS SPECTROMETRY; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; PROTEOMICS; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMOYLATION; TANDEM MASS SPECTROMETRY;

EID: 84931282084     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8289     Document Type: Article

References (63)

1. Vertegaal, A. C. Uncovering ubiquitin and ubiquitin-like signaling networks. Chem. Rev. 111, 7923-7940 (2011).
2. Hay, R. T. SUMO: a history of modification. Mol. Cell 18, 1-12 (2005).
3. Geiss-Friedlander, R. & Melchior, F. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 8, 947-956 (2007).
4. Jackson, S. P. & Durocher, D. Regulation of DNA damage responses by ubiquitin and SUMO. Mol. Cell 49, 795-807 (2013).
5. Ulrich, H. D. & Walden, H. Ubiquitin signalling in DNA replication and repair. Nat. Rev. Mol. Cell Biol. 11, 479-489 (2010).
6. Gill, G. Something about SUMO inhibits transcription. Curr. Opin. Genet. Dev 15, 536-541 (2005).
7. Mukhopadhyay, D. & Dasso, M. Modification in reverse: the SUMO proteases. Trends Biochem. Sci. 32, 286-295 (2007).
8. Flotho, A. & Melchior, F. Sumoylation: a regulatory protein modification in health and disease. Annu. Rev. Biochem. 82, 357-385 (2013).
9. Rodriguez, M. S., Dargemont, C. & Hay, R. T. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276, 12654-12659 (2001).
10. Sampson, D. A., Wang, M. & Matunis, M. J. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J. Biol. Chem. 276, 21664-21669 (2001).
11. Nacerddine, K. et al. The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Dev. Cell 9, 769-779 (2005).
12. Wang, L. et al. SUMO2 is essential while SUMO3 is dispensable for mouse embryonic development. EMBO Rep. 15, 878-885 (2014).
13. Wang, Y. & Dasso, M. SUMOylation and deSUMOylation at a glance. J. Cell Sci. 122, 4249-4252 (2009).
14. Saitoh, H. & Hinchey, J. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J. Biol. Chem. 275, 6252-6258 (2000).
15. Becker, J. et al. Detecting endogenous SUMO targets in mammalian cells and tissues. Nat. Struct. Mol. Biol. 20, 525-531 (2013).
16. Vertegaal, A. C. et al. Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics. Mol. Cell Proteomics 5, 2298-2310 (2006).
17. Vertegaal, A. C. SUMO chains: polymeric signals. Biochem. Soc. Trans. 38, 46-49 (2010).
18. Tatham, M. H. et al. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J. Biol. Chem. 276, 35368-35374 (2001).
19. Golebiowski, F. et al. System-wide changes to SUMO modifications in response to heat shock. Sci. Signal. 2, ra24 (2009).
20. Burgess, R. C., Rahman, S., Lisby, M., Rothstein, R. & Zhao, X. The Slx5-Slx8 complex affects sumoylation of DNA repair proteins and negatively regulates recombination. Mol. Cell Biol. 27, 6153-6162 (2007).
21. Perry, J. J., Tainer, J. A. & Boddy, M. N. A SIM-ultaneous role for SUMO and ubiquitin. Trends Biochem. Sci. 33, 201-208 (2008).
22. Sun, H., Leverson, J. D. & Hunter, T. Conserved function of RNF4 family proteins in eukaryotes: targeting a ubiquitin ligase to SUMOylated proteins. EMBO J. 26, 4102-4112 (2007).
23. Tatham, M. H. et al. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat. Cell Biol. 10, 538-546 (2008).
24. Mahajan, R., Delphin, C., Guan, T., Gerace, L. & Melchior, F. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88, 97-107 (1997).
25. Lin, D. Y. et al. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol. Cell 24, 341-354 (2006).
26. Mei, D. et al. Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association. Med. Oncol. 30, 709 (2013).
27. Kessler, J. D. et al. A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis. Science 335, 348-353 (2012).
28. Wang, Q. et al. SUMO-specific protease 1 promotes prostate cancer progression and metastasis. Oncogene 32, 2493-2498 (2013).
29. Bettermann, K., Benesch, M., Weis, S. & Haybaeck, J. SUMOylation in carcinogenesis. Cancer Lett. 316, 113-125 (2012).
30. Schimmel, J. et al. The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle. Mol. Cell Proteomics 7, 2107-2122 (2008).
31. Bruderer, R. et al. Purification and identification of endogenous polySUMO conjugates. EMBO Rep. 12, 142-148 (2011).
32. Hendriks, I. A. et al. Uncovering global SUMOylation signaling networks in a site-specific manner. Nat. Struct. Mol. Biol. 21, 927-936 (2014).
33. Tammsalu, T. et al. Proteome-wide identification of SUMO2 modification sites. Sci. Signal. 7, rs2 (2014).
34. Witze, E. S., Old, W. M., Resing, K. A. & Ahn, N. G. Mapping protein posttranslational modifications with mass spectrometry. Nat. Methods 4, 798-806 (2007).
35. Pandey, A. & Mann, M. Proteomics to study genes and genomes. Nature 405, 837-846 (2000).
36. Mann, M. & Jensen, O. N. Proteomic analysis of post-translational modifications. Nat. Biotechnol. 21, 255-261 (2003).
37. Olsen, J. V. & Mann, M. Status of large-scale analysis of post-translational modifications by mass spectrometry. Mol. Cell Proteomics 12, 3444-3452 (2013).
38. Huttlin, E. L. et al. A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 143, 1174-1189 (2010).
39. Olsen, J. V. et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127, 635-648 (2006).
40. Choudhary, C. et al. Lysine acetylation targets protein complexes and coregulates major cellular functions. Science 325, 834-840 (2009).
41. Guo, A. et al. Immunoaffinity enrichment and mass spectrometry analysis of protein methylation. Mol. Cell Proteomics 13, 372-387 (2013).
42. Kim, D. Y., Scalf, M., Smith, L. M. & Vierstra, R. D. Advanced proteomic analyses yield a deep catalog of ubiquitylation targets in Arabidopsis. Plant Cell 25, 1523-1540 (2013).
43. Emanuele, M. J. et al. Global identification of modular cullin-RING ligase substrates. Cell 147, 459-474 (2011).
44. Povlsen, L. K. et al. Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass. Nat. Cell Biol. 14, 1089-1098 (2012).
45. Wagner, S. A. et al. A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol. Cell Proteomics 10, M111.013284 (2011).
46. Kim, W. et al. Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol. Cell 44, 325-340 (2011).
47. Galisson, F. et al. A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cells. Mol. Cell Proteomics 10, M110.004796 (2011).
48. Matic, I. et al. Site-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif. Mol. Cell 39, 641-652 (2010).
49. Schimmel, J. et al. Uncovering SUMOylation dynamics during Cell-Cycle Progression Reveals FoxM1 as a key mitotic SUMO target protein. Mol. Cell 53, 1053-1066 (2014).
50. Franceschini, A. et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41, D808-D815 (2013).
51. Yunus, A. A. & Lima, C. D. Purification and activity assays for Ubc9, the ubiquitin-conjugating enzyme for the small ubiquitin-like modifier SUMO. Methods Enzymol. 398, 74-87 (2005).
52. Andersen, J. L. et al. A biotin switch-based proteomics approach identifies 14-3-3zeta as a target of Sirt1 in the metabolic regulation of caspase-2. Mol. Cell 43, 834-842 (2011).
53. Stes, E. et al. A COFRADIC protocol to study protein ubiquitination. J. Proteome Res. 13, 3107-3113 (2014).
54. Vellinga, J. et al. A system for efficient generation of adenovirus protein IX-producing helper cell lines. J. Gene Med. 8, 147-154 (2006).
55. Rappsilber, J., Mann, M. & Ishihama, Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2, 1896-1906 (2007).
56. Vizcaino, J. A. et al. ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat. Biotechnol. 32, 223-226 (2014).
57. Cox, J. et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 10, 1794-1805 (2011).
58. Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367-1372 (2008).
59. Colaert, N., Helsens, K., Martens, L., Vandekerckhove, J. & Gevaert, K. Improved visualization of protein consensus sequences by iceLogo. Nat. Methods 6, 786-787 (2009).
60. Cox, J. & Mann, M. 1D and 2D annotation enrichment: a statistical method integrating quantitative proteomics with complementary high-throughput data. BMC Bioinformatics 13(Suppl 16): S12 (2012).
61. Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25-29 (2000).
62. Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498-2504 (2003).
63. Hornbeck, P. V. et al. PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res. 40, D261-D270 (2012).